PharmaFluidics
Enterprise number 0832350565 · Active (000 Normale toestand)
PharmaFluidics is a naamloze vennootschap registered in Gent, Belgium, incorporated on 29 Dec 2010. Its registered activity is overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied.
Company details
- Enterprise number
- 0832350565 · official register
- Status
- 000 Normale toestand
- Legal form
- Naamloze vennootschap
- Incorporated
- 29 Dec 2010 (16 years)
- Registered address
- 9052 Gent
- Province
- East Flanders
- Activity
- 72190 Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
- Industry
- Scientific research and development
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in East Flanders
- 360SURVEY Aalst
- 4U2 PATENT SERVICE Oudenaarde
- ABLYNX Gent
- ADRIAENS CONSULTING Aalter
- AEPHIS CONSULTING Gent
- AETHER RENEWABLE CHEMICALS Gent
- AJ Daly Consulting Gent
- AMBERCO Gent
- APOTHEKER-BIOLOOG DIMITRI BAETENS Lokeren
- AREADNE Temse
- ART-COMPANY Evergem
- ASTERION RESEARCH & DEVELOPMENT Gent
Questions about PharmaFluidics
What is the enterprise number of PharmaFluidics?
PharmaFluidics is registered under enterprise number 0832350565 in the official register of Belgium. View it at the official register.
Is PharmaFluidics still active?
Yes. PharmaFluidics is registered as active (status: 000 Normale toestand).
Has PharmaFluidics gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for PharmaFluidics in the official data.
When was PharmaFluidics founded?
PharmaFluidics was incorporated on 29 Dec 2010.
Where is PharmaFluidics registered?
PharmaFluidics's registered address is in 9052 Gent (East Flanders), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.